No reviews yet. Share the first one.
Psychedelic medicine developer
Entropy Neurodynamics Limited, formerly Tryptamine Therapeutics Limited, is an active psychedelic medicine developer headquartered in Melbourne, Victoria, Australia. Its pipeline includes psilocin and psilocybin candidates intended for use with psychotherapy. Development includes clinical programs from Phase 2a through Phase 2, as well as a planned Phase 2 study. All candidates are investigational and are not available to buy.
All products · Psychedelic medicine pipeline
2 items across 1 shelf